Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: A prospective cohort study from Burkina Faso

Sexually Transmitted Infections

Volumn 90, Issue 2, 2014, Pages 100-103

  Low, Andrea J ^a   Konate, Issouf ^b   Nagot, Nicolas ^b,c   Weiss, Helen A ^a   Mabey, David ^a   Segondy, Michel ^c   Vickerman, Peter ^a   Meda, Nicolas ^b   De Perre, Philippe Van ^b,c   Mayaud, Philippe ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CENTRE MURAZ   (Burkina Faso)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL FACTOR; VIRUS RNA;

ADULT; ARTICLE; BURKINA FASO; CHLAMYDIASIS; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GONORRHEA; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TOBACCO USE;

AFRICA; ANTERETROVIRAL THERAPY; CHLAMYDIA INFECTION; GONORRHOEA; HIV;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BURKINA FASO; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; COINFECTION; FEMALE; GONORRHEA; HIV INFECTIONS; HIV-1; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEEDS ASSESSMENT; NEISSERIA GONORRHOEAE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENTINEL SURVEILLANCE; SEXUAL BEHAVIOR;

EID: 84895538684     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2013-051233     Document Type: Article

References (10)

1. Nagot N, Meda N, Ouangre A, et al. Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV control. Sex Transm Infect 2004;80:124-129.
2. Behanzin L, Diabate S, Minani I, et al. Decline in the prevalence of HIV and sexually transmitted infections among female sex workers in Benin over 15 years of targeted interventions. J Acquir Immune Defic Syndr 2013;63:126-134.
3. Nagot N, Ouangre A, Ouedraogo A, et al. Spectrum of commercial sex activity in Burkina Faso: classification model and risk of exposure to HIV. J Acquir Immune Defic Syndr 2002;29:517-521.
4. Nagot N, Foulongne V, Becquart P, et al. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. J Acquir Immune Defic Syndr 2005;39:632-634.
5. Wolf R, Freedman D. Cigarette smoking, sexually transmitted diseases, and HIV/AIDS. Int J Derm 2000;39:1-9.
6. Lieberman JA, Moscicki AB, Sumerel JL, et al. Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates. Clin Vaccine Immunol 2008;15: 49-54.
7. Lavreys L, Chohan V, Overbaugh J, et al. Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS 2004;18:2179-2184.
8. Kaushic C, Roth KL, Anipindi V, et al. Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses. J Reprod Immunol 2011;88:204-209.
9. Mohllajee AP, Curtis KM, Martins SL, et al. Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review. Contraception 2006;73:154-165.
10. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008;35:946-959.